Fosfomycin tromethamine activity on biofilm and intracellular bacterial communities produced by uropathogenic Escherichia coli isolated from patients with urinary tract infection
Authors:
- 1 April 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Pathogens and Disease
- Vol. 77 (3)
Abstract
Fosfomycin tromethamine (FT), an old antibiotic revived as a new strategy to overcome antibiotic resistance, is an excellent option for the treatment of lower urinary tract infection (UTI). During UTI, Escherichia coli produces biofilms and could invade the bladder epithelial cells, developing intracellular bacterial communities (IBC). The present work aimed to evaluate the activity of FT on biofilms and IBC from clinical isolates of E. coli. A total of 38 E. coli clinical UTI isolates previously characterized as biofilm and IBC producers were studied. FT susceptibility was evaluated and its activity on 48 h biofilm was determined by microtiter plate-based biofilm assay comparing three different antibiotic concentrations. Two UPEC strains were selected to evaluate FT activity on IBC in vitro using T24 bladder cells. The survival percentage of intracellular bacteria after 24 h exposure to FT was calculated and compared to the percentage of intracellular bacteria without antibiotic. All the strains were susceptible to FT. FT produced a significant reduction of biofilms at the three concentrations tested, compared to the control. However, no statistically effect on IBC was observed after 24 h of fosfomycin exposure in cell culture. FT is a good option for bacterial biofilm reduction within UTI. However, it does not affect IBC.Keywords
This publication has 32 references indexed in Scilit:
- Biofilm formation by clinical isolates and the implications in chronic infectionsBMC Infectious Diseases, 2013
- Escherichia coli Uropathogenesis In Vitro : Invasion, Cellular Escape, and Secondary Infection Analyzed in a Human Bladder Cell Infection ModelInfection and Immunity, 2012
- The biofilm matrixNature Reviews Microbiology, 2010
- Persistence of Uropathogenic Escherichia coli in the Face of Multiple AntibioticsAntimicrobial Agents and Chemotherapy, 2010
- Fosfomycin: an old, new friend?European Journal of Clinical Microbiology & Infectious Diseases, 2009
- Detection of Intracellular Bacterial Communities in Human Urinary Tract InfectionPLOS Medicine, 2007
- Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin/clavulanic acid and co-trimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilmsInternational Journal of Antimicrobial Agents, 2007
- Specialized Persister Cells and the Mechanism of Multidrug Tolerance in Escherichia coliJournal of Bacteriology, 2004
- Intracellular bacterial communities of uropathogenic in urinary tract pathogenesisTrends in Microbiology, 2004
- Antibacterial spectrum of fosfomycin trometamolJournal of Antimicrobial Chemotherapy, 1995